SEOUL: Samsung Electronics is expected to forecast a 39% plunge in second-quarter operating profit on Tuesday, weighed down ...

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, is pleased to announce that the first ...

Samsung Electronics is expected to forecast a 39% plunge in second-quarter operating profit on Tuesday, weighed down by ...

If you want cutting-edge performance at 1080p and even solid 1440p gaming in 2025, this build delivers it without blowing ...